Terry Kelley
Obstetrics & Gynecology · Marietta, GANPI 1700836269
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2022 at $637 and has fallen 80.2% since, to $126 in 2024.
Across 105 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$591
- Mayne Pharma Commercial LLC$283
- Aspira Women's Health Inc$134
- Therapeuticsmd, Inc.$117
- Pfizer$86
- Coopersurgical, Inc.$84
- plus $683 from 21 others
What the payments were for
- Food & beverage$1,96199%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $591 |
| Mayne Pharma Commercial LLC | 14 | $283 |
| Aspira Women's Health Inc | 1 | $134 |
| Therapeuticsmd, Inc. | 8 | $117 |
| Pfizer | 6 | $86 |
| Coopersurgical, Inc. | 5 | $84 |
| Astellas Pharma US Inc | 4 | $67 |
| Duchesnay USA Incorporated | 4 | $60 |
| Revance Therapeutics, Inc. | 1 | $56 |
| Bayer | 3 | $55 |
| Evofem Biosciences, Inc. | 3 | $49 |
| Daiichi Sankyo Inc. | 3 | $48 |
| Boston Scientific | 3 | $48 |
| Exeltis, USA Inc. | 3 | $47 |
| Hologic Sales And Service, LLC | 2 | $30 |
| Myovant Sciences Inc. | 1 | $29 |
| Organon | 2 | $29 |
| Avion Pharmaceuticals | 2 | $25 |
| Millicent US Inc | 1 | $21 |
| Shield Therapeutics Inc | 1 | $19 |
| Alydia Health | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Channel Medsystems, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OVA1$134
How this compares
$1,978 in reported general payments places this provider in the 70th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 22 | $1,447 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Marietta
- Teresa ByrdMarietta$41K
- Eduardo EstrellaMarietta$26K
- Jeffrey MarcusMarietta$12K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.